About NAVERIS INC
Naveris develops highly sensitive blood tests, liquid biopsies, that identify viral cancers significantly earlier than is possible with scans or traditional biopsies. Their lead product, NavDx®, is a liquid biopsy that uses proprietary technology to enable ultrasensitive surveillance of HPV-related cancer.
Development of highly sensitive blood testsCreation of liquid biopsies for early cancer detectionReal-time monitoring of cancer response in patients undergoing treatmentDetection of cancer recurrence for patients in remission
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| NAVDX BLOOD TESTING | Department of Veterans Affairs | $7K | |
| NAVDX BLOOD TESTING | Department of Veterans Affairs | $35K | |
| CANCER TESTING SERVICES FOR THE LAB AT NAVAL MEDICAL CENTER SAN DIEGO CA | Department of Defense | $35K | |
| NAVDX BLOOD TESTING | Department of Veterans Affairs | $11K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NAVERIS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.